Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: Results from a randomized controlled trial
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Unlabelled The effects of treatment with 100 μg parathyroid hormone (PTH) (1-84) or an identical placebo on muscle function and quality of life (QoL) was studied in hypoparathyroid patients. At baseline, we found reduced QoL but no myopathy in the patients. Six months of treatment did not improve QoL, and muscle strength decreased slightly.Introduction A reduced quality of life (QoL) and myopathy that may be due to the absence of PTH have been reported in patients with hypoparathyroidism (hypoPT).Methods Sixty-two patients with chronic hypoPT were randomized to 6 months of treatment with either PTH(1-84) 100 μg/d s.c. or placebo, given as add-on therapy to conventional treatment. Muscle function and postural stability were investigated using a dynamometer chair, a stadiometer platform, the repeated chair stands test, the timed up and go test, and electromyography. QoL was assessed using the 36-item Short Form Health Survey and the WHO-5 Well-Being Index.Results The mean age of the patients was 52 ± 11 years, and 85 % were females. At baseline, QoL was significantly reduced in comparison with norm-based scores. Compared with placebo, PTH did not improve QoL or muscle function. Rather, max force production decreased significantly by 30 % at elbow flexion in the PTH group compared with the placebo group. Moreover, there was a nonsignificant trend for muscle strength to decrease in the upper extremities and on knee extension in response to PTH. Treatment did not affect postural stability. Electromyography showed a slight decrease in the duration of motor unit potentials in the PTH group, indicating a tendency toward myopathy, which, however was not symptomatic.Conclusions Overall, our data do not support an immediate beneficial effect of PTH replacement therapy on muscle function or QoL. A high frequency of hypercalcemia among our patients may have compromised the potential beneficial effects of reversing the state of PTH insufficiency.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PTH replacement in hypothyroid patients can decrease maximal muscle strength by ~30% and can impair neuromuscular motor unit action potentials [90].”
From The Role of Mineral and Trace Element Supplementation in Exercise and Athletic Performance: A Systematic Review (2019) · cites this paper as [90]
Citations
Cites
The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons
Podsiadlo, D., & Richardson, S. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb01616.x · Cited by 14,418 · cited 3×
“In the “timed up and go” (TUG) test [22], the patient was placed in a chair with arms crossed in front of the chest.”
BackgroundMethodSF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
Steffen, T. M., Hacker, T. A., & Mollinger, L. (2002) · Physical Therapy · doi:10.1093/ptj/82.2.128 · Cited by 2,070
Turner‐Bowker, D. M., DeRosa, M., & Ware, J. E. (2008) · eScholarship@UMassChan · Cited by 954
Simple method for measurement of lower extremity muscle strength
Csuka, M., & McCarty, D. J. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90465-6 · Cited by 891
Postural Balance in a Random Sample of 7,979 Subjects Aged 30 Years and Over
Era, P., Sainio, P., Koskinen, S., Haavisto, P., Vaara, M., & Aromaa, A. (2006) · Gerontology · doi:10.1159/000093652 · Cited by 421
Validation of the WHO-5 Well-Being Index in Adolescents With Type 1 Diabetes
de Wit, M., Pouwer, F., Gemke, R. J. B. J., Delemarre-van de Waal, H. A., & Snoek, F. J. (2007) · Diabetes Care · doi:10.2337/dc07-0447 · Cited by 335
Winer, K. K., Ko, C. W., Reynolds, J. C., Dowdy, K., Keil, M., Peterson, D., Gerber, L. H., McGarvey, C., & Cutler, G. B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021736 · Cited by 312
The association between timed up and go test and history of falls: The Tromsø study
Thrane, G., Joakimsen, R. M., & Thornquist, E. (2007) · BMC Geriatrics · doi:10.1186/1471-2318-7-1 · Cited by 256
Arlt, W., Fremerey, C., Callies, F., Reincke, M., Schneider, P., Timmermann, W., & Allolio, B. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460215 · Cited by 254
(2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1908 · Cited by 235
Buchthal, F., & Kamieniecka, Z. (1982) · Muscle & Nerve · doi:10.1002/mus.880050403 · Cited by 200
Winer, K. K. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.10.3480 · Cited by 189
Sikjaer, T., Rejnmark, L., Rolighed, L., Heickendorff, L., Mosekilde, L., & the Hypoparathyroid Study Group (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.470 · Cited by 188
Self-citationThe Effect of PTH(1–84) on Quality of Life in Hypoparathyroidism
Cusano, N. E., Rubin, M. R., McMahon, D. J., Irani, D., Tulley, A., Sliney, J., & Bilezikian, J. P. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1239 · Cited by 187
Divieti, P., Inomata, N., Chapin, K., Singh, R., Jüppner, H., & Bringhurst, F. R. (2001) · Endocrinology · doi:10.1210/endo.142.2.7955 · Cited by 169
Winer, K. K., Sinaii, N., Peterson, D., Sáinz, B., & Cutler, G. B. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2552 · Cited by 161
The role of different EMG methods in evaluating myopathy
Fuglsang‐Frederiksen, A. (2006) · Clinical Neurophysiology · doi:10.1016/j.clinph.2005.12.018 · Cited by 118
Self-citationTOXIC AMBLYOPIA DURING ANTIDEPRESSANT TREATMENT WITH PHENIPRAZINE (CATRAN®)
Frandsen, E. (1962) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1962.tb01780.x · Cited by 103
Analysis of electrical activity of normal muscle in man at different degrees of voluntary effort.
Fuglsang‐Frederiksen, A., & Mansson, A. (1975) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.38.7.683 · Cited by 97
Self-citationSikjær, T., Amstrup, A. K., Rolighed, L., Kjaer, S. G., Mosekilde, L., & Rejnmark, L. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1964 · Cited by 88
Self-citationSikjær, T., Rejnmark, L., Thomsen, J. S., Tietze, A., Brüel, A., Andersen, G., & Mosekilde, L. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1493 · Cited by 82
Self-citationMolecular Mechanisms of Ligand Recognition by Parathyroid Hormone 1 (PTH1) and PTH2 Receptors.
Hoare, S., & Usdin, T. B. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013397825 · Cited by 69
The psychiatric aspects of hypoparathyroidism.
Denko, J. D., & Kaelbling, R. (1962) · PubMed · Cited by 64
A Rare Case of Idiopathic Hypoparathyroidism with Varied Neurological Manifestations.
Seijirou, A. B. E., Tojo, K., Ichida, K., Shigematsu, T., Hasegawa, T., Morita, M., & Sakai, O. (1996) · Internal Medicine · doi:10.2169/internalmedicine.35.129 · Cited by 57
Rantanen, T., Era, P., & Heikkinen, E. (2019) · Journal of Rehabilitation Medicine · doi:10.2340/1650197719962828993 · Cited by 57
The Parathyroid Hormone 2 (PTH2) Receptor
Usdin, T. B., Bonner, T. I., & Hoare, S. R. J. (2002) · Receptors and Channels · doi:10.3109/10606820213682 · Cited by 54
Tiainen, K., Sipilä, S., Kauppinen, M., Kaprio, J., & Rantanen, T. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91056.2008 · Cited by 45
Reppe, S., Stilgren, L. S., Abrahamsen, B., Olstad, O. K., Cero, F. T., Brixen, K., Nissen‐Meyer, L. S. H., & Gautvik, K. M. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00487.2006 · Cited by 45
The Parathyroid Hormone 2 (PTH2) Receptor
Usdin, T. B., Bonner, T. I., & Hoare, S. R. J. (2002) · Receptors and Channels · doi:10.1080/10606820213682 · Cited by 43
Psychiatric Aspects of Parathyroid Disease
Velasco, P. J., Manshadi, M., Breen, K., & Lippmann, S. (1999) · Psychosomatics · doi:10.1016/s0033-3182(99)71186-2 · Cited by 41
Hypoparathyroidism and elevated muscle enzymes
Shane, E. J., McClane, K. A., Olarte, M. R., & Bilezikian, J. P. (1980) · Neurology · doi:10.1212/wnl.30.2.192 · Cited by 39
Liguori, R., Dahl, K., Fuglsang‐Frederiksen, A., & Trojaborg, W. (1992) · Muscle & Nerve · doi:10.1002/mus.880151205 · Cited by 38
Self-citationHypocalcaemic myopathy with paranoid psychosis
Snowdon, J. A., Macfie, A., & Pearce, J. B. (1976) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.39.1.48 · Cited by 35
Idiopathic hypoparathyroidism with extrapyramidal and myopathic features.
Walters, R. O. (1979) · Archives of Disease in Childhood · doi:10.1136/adc.54.3.236 · Cited by 32
Turns analysis (peak ratio) in EMG using the mean amplitude as a substitute of force measurement
Fuglsang‐Frederiksen, A., Monaco, M. L., & Dahl, K. (1985) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(85)90035-5 · Cited by 30
Self-citationHypocalcemic myopathy without tetany due to idiopathic hypoparathyroidism: case report
Nora, D. B., Fricke, D., Becker, J., & Gomes, I. (2004) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2004000100028 · Cited by 28
Muscle histology of hypocalcaemic myopathy in hypoparathyroidism.
Yamaguchi, H., Okamoto, K., Shooji, M., Morimatsu, M., & Hirai, S. (1987) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.50.6.817 · Cited by 26
Depression as a manifestation of latent chronic hypoparathyroidism
Bohrer, T., & Krannich, J.-H. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970600995146 · Cited by 26
Syriou, V., Kolitsa, A., Pantazi, L., & Pikazis, D. (2005) · HORMONES · doi:10.14310/horm.2002.11154 · Cited by 21
Ceria‐Ulep, C. D., Grove, J., Chen, R., Masaki, K., Rodríguez, B. L., Donlon, T. A., Guralnik, J. M., Willcox, B. J., Willcox, D. C., Nigg, C. R., et al. (2010) · Current Gerontology and Geriatrics Research · doi:10.1155/2010/849761 · Cited by 15
Liu, M.-F., Chen, F.-F., Hsiue, T.-R., & Liu, C.-C. (2000) · Clinical Rheumatology · doi:10.1007/s100670050014 · Cited by 14
Hypocalcemia, hypoparathyroidism, and organic anxiety syndrome.
Ba, L. (1988) · PubMed · Cited by 13
Smock, S. L., Vogt, G. A., Castleberry, T. A., Lu, B., & Owen, T. A. (2001) · Molecular Biology Reports · doi:10.1023/a:1015716726452 · Cited by 11
LaJeunesse, C., Everett, J., Laplante, L., Villeneuve, A., Côté, R., & Thomas, J. E. (1989) · PubMed · Cited by 1
Research works printed but not linked: 1
- Van Offel JF, De Gendt CM, De Clerck LS, Stevens WJ (2000) High bone mass and hypocalcaemic myopathy in a patient with idiopathic hypoparathyroidism. Clin Rheumatol 19:64–66
Cited by
Bollerslev, J., Rejnmark, L., Marcocci, C., Shoback, D. M., Sitges-Serra, A., van Biesen, W., & Dekkers, O. M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0628 · Cited by 462
Self-citationManagement of Hypoparathyroidism: Summary Statement and Guidelines
Brandi, M. L., Bilezikian, J. P., Shoback, D., Bouillon, R., Clarke, B. L., Thakker, R. V., Khan, A. A., & Potts, J. T. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3907 · Cited by 436
Presentation of Hypoparathyroidism: Etiologies and Clinical Features
Shoback, D. M., Bilezikian, J. P., Costa, A. G., Dempster, D., Dralle, H., Khan, A. A., Peacock, M., Raffaelli, M., Silva, B. C., Thakker, R. V., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3909 · Cited by 371
The Epidemiology of Nonsurgical Hypoparathyroidism in Denmark: A Nationwide Case Finding Study
Underbjerg, L., Sikjaer, T., Mosekilde, L., & Rejnmark, L. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2501 · Cited by 245
Self-citationEpidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway
Astor, M. C., Løvås, K., Debowska, A., Eriksen, E. F., Evang, J. A., Fossum, C., Fougner, K. J., Holte, S. E., Lima, K., Moe, R. B., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1477 · Cited by 240
Metadata
- Authors
- Sikjaer, T., Rolighed, L., Hess, A., Fuglsang-Frederiksen, A., Mosekilde, L., & Rejnmark, L.
- Affiliations
- Aarhus University Hospital (DK)
- Venue
- Osteoporosis International
- Published
- 2014-04-01
- Volume
- 25
- Issue
- 6
- Pages
- 1717-1726
- ISSN
- 0937-941X (ISSN-L)
- 1433-2965
- OpenAlex
- W2091222735
- Cited by
- 134
- References
- 44
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 7 · 2023: 10 · 2022: 5 · 2021: 14 · 2020: 19 · 2019: 17 · 2018: 14 · 2017: 12 · 2016: 7 · 2015: 11 · 2014: 4
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Osteoporosis International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- parathyroid hormone 1-84, hypoparathyroidism, parathyroid hormone replacement therapy, muscle function, muscle strength, quality of life, myopathy, postural stability, hypercalcemia, electromyography, motor unit action potentials
- MeSH terms
- Adult, Aged, Body Composition, Double-Blind Method, Electromyography, Postural Balance, Female, Humans, Hypoparathyroidism, Male, Middle Aged, Parathyroid Hormone, Psychometrics, Quality of Life, Treatment Outcome, Muscle, Skeletal, Hormone Replacement Therapy, Muscle Strength
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.